News & Updates

Show Multimedia Only

Gout patients at risk of developing depression, anxiety

03 Feb 2021

The odds of developing depression and anxiety are high among patients with gout, suggest the results of a systematic review and meta-analysis.

Gout patients at risk of developing depression, anxiety

03 Feb 2021

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

02 Feb 2021

Treatment discontinuation with tofacitinib is common in patients with rheumatoid arthritis (RA) despite its ease of administration, reports a new study.

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

02 Feb 2021

Long-term tacrolimus therapy safe, effective in lupus nephritis

02 Feb 2021 by

Maintenance treatment with tacrolimus in patients with lupus nephritis (LN) over 5 years is effective and well tolerated in the real-world clinical setting, results of a postmarketing surveillance (PMS) study in Japan have shown.

Long-term tacrolimus therapy safe, effective in lupus nephritis

02 Feb 2021

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Gout patients at risk of developing depression, anxiety

Gout patients at risk of developing depression, anxiety

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

Long-term tacrolimus therapy safe, effective in lupus nephritis

Long-term tacrolimus therapy safe, effective in lupus nephritis